Does BROLUCIZUMAB Cause Ocular hyperaemia? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Ocular hyperaemia have been filed in association with BROLUCIZUMAB (BEOVU). This represents 9.1% of all adverse event reports for BROLUCIZUMAB.
62
Reports of Ocular hyperaemia with BROLUCIZUMAB
9.1%
of all BROLUCIZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Ocular hyperaemia From BROLUCIZUMAB?
Of the 62 reports, 4 (6.5%) required hospitalization.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB Cause?
Visual impairment (116)
Vision blurred (106)
Eye pain (81)
Vitreous floaters (74)
Vitritis (65)
Off label use (62)
Subretinal fluid (62)
Retinal vasculitis (52)
Eye inflammation (50)
Visual acuity reduced (50)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which BROLUCIZUMAB Alternatives Have Lower Ocular hyperaemia Risk?
BROLUCIZUMAB vs BROLUCIZUMAB-DBLL
BROLUCIZUMAB vs BROMAZEPAM
BROLUCIZUMAB vs BROMFENAC
BROLUCIZUMAB vs BROMHEXINE
BROLUCIZUMAB vs BROMOCRIPTINE